These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 22750429

  • 21. Identification and Pharmaceutical Characterization of a New Itraconazole Terephthalic Acid Cocrystal.
    Machado Cruz R, Boleslavská T, Beránek J, Tieger E, Twamley B, Santos-Martinez MJ, Dammer O, Tajber L.
    Pharmaceutics; 2020 Aug 06; 12(8):. PubMed ID: 32781726
    [Abstract] [Full Text] [Related]

  • 22. High speed electrospinning for scaled-up production of amorphous solid dispersion of itraconazole.
    Nagy ZK, Balogh A, Démuth B, Pataki H, Vigh T, Szabó B, Molnár K, Schmidt BT, Horák P, Marosi G, Verreck G, Van Assche I, Brewster ME.
    Int J Pharm; 2015 Mar 01; 480(1-2):137-42. PubMed ID: 25596415
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Formation mechanism of a new carbamazepine/malonic acid cocrystal polymorph.
    Limwikrant W, Nagai A, Hagiwara Y, Higashi K, Yamamoto K, Moribe K.
    Int J Pharm; 2012 Jul 15; 431(1-2):237-40. PubMed ID: 22537807
    [Abstract] [Full Text] [Related]

  • 26. Following the surface response of caffeine cocrystals to controlled humidity storage by atomic force microscopy.
    Cassidy AM, Gardner CE, Jones W.
    Int J Pharm; 2009 Sep 08; 379(1):59-66. PubMed ID: 19539735
    [Abstract] [Full Text] [Related]

  • 27. Use of pharmaceutical salts and cocrystals to address the issue of poor solubility.
    Elder DP, Holm R, Diego HL.
    Int J Pharm; 2013 Aug 30; 453(1):88-100. PubMed ID: 23182973
    [Abstract] [Full Text] [Related]

  • 28. Lubricant-Induced Crystallization of Itraconazole From Tablets Made of Electrospun Amorphous Solid Dispersion.
    Démuth B, Farkas A, Balogh A, Bartosiewicz K, Kállai-Szabó B, Bertels J, Vigh T, Mensch J, Verreck G, Van Assche I, Marosi G, Nagy ZK.
    J Pharm Sci; 2016 Sep 30; 105(9):2982-2988. PubMed ID: 27290626
    [Abstract] [Full Text] [Related]

  • 29. Cocrystal and Salt Forms of an Imidazopyridazine Antimalarial Drug Lead.
    Noonan TJ, Chibale K, Cheuka PM, Bourne SA, Caira MR.
    J Pharm Sci; 2019 Jul 30; 108(7):2349-2357. PubMed ID: 30817923
    [Abstract] [Full Text] [Related]

  • 30. Physical stability enhancement of theophylline via cocrystallization.
    Trask AV, Motherwell WD, Jones W.
    Int J Pharm; 2006 Aug 31; 320(1-2):114-23. PubMed ID: 16769188
    [Abstract] [Full Text] [Related]

  • 31. Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid.
    Li Z, Matzger AJ.
    Mol Pharm; 2016 Mar 07; 13(3):990-5. PubMed ID: 26837376
    [Abstract] [Full Text] [Related]

  • 32. Investigating the effect of moisture protection on solid-state stability and dissolution of fenofibrate and ketoconazole solid dispersions using PXRD, HSDSC and Raman microscopy.
    Kanaujia P, Lau G, Ng WK, Widjaja E, Schreyer M, Hanefeld A, Fischbach M, Saal C, Maio M, Tan RB.
    Drug Dev Ind Pharm; 2011 Sep 07; 37(9):1026-35. PubMed ID: 21417604
    [Abstract] [Full Text] [Related]

  • 33. Laponite-based nanohybrid for enhanced solubility and controlled release of itraconazole.
    Jung H, Kim HM, Choy YB, Hwang SJ, Choy JH.
    Int J Pharm; 2008 Feb 12; 349(1-2):283-90. PubMed ID: 17888597
    [Abstract] [Full Text] [Related]

  • 34. In Vitro-In Vivo Correlation in Cocrystal Dissolution: Consideration of Drug Release Profiles Based on Coformer Dissolution and Absorption Behavior.
    Kataoka M, Minami K, Takagi T, Amidon GE, Yamashita S.
    Mol Pharm; 2021 Nov 01; 18(11):4122-4130. PubMed ID: 34618448
    [Abstract] [Full Text] [Related]

  • 35. Salt Disproportionation in the Solid State: Role of Solubility and Counterion Volatility.
    Thakral NK, Behme RJ, Aburub A, Peterson JA, Woods TA, Diseroad BA, Suryanarayanan R, Stephenson GA.
    Mol Pharm; 2016 Dec 05; 13(12):4141-4151. PubMed ID: 27766882
    [Abstract] [Full Text] [Related]

  • 36. In vitro evaluation of the dissolution behaviour of itraconazole in bio-relevant media.
    Ghazal HS, Dyas AM, Ford JL, Hutcheon GA.
    Int J Pharm; 2009 Jan 21; 366(1-2):117-23. PubMed ID: 18832020
    [Abstract] [Full Text] [Related]

  • 37. Effect of counterions on the properties of amorphous atorvastatin salts.
    Sonje VM, Kumar L, Puri V, Kohli G, Kaushal AM, Bansal AK.
    Eur J Pharm Sci; 2011 Nov 20; 44(4):462-70. PubMed ID: 21907794
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Dissolution improvement and the mechanism of the improvement from cocrystallization of poorly water-soluble compounds.
    Shiraki K, Takata N, Takano R, Hayashi Y, Terada K.
    Pharm Res; 2008 Nov 20; 25(11):2581-92. PubMed ID: 18651208
    [Abstract] [Full Text] [Related]

  • 40. The influence of aqueous content in small scale salt screening--improving hit rate for weakly basic, low solubility drugs.
    Tarsa PB, Towler CS, Woollam G, Berghausen J.
    Eur J Pharm Sci; 2010 Sep 11; 41(1):23-30. PubMed ID: 20553863
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.